TEVA PHARMACEUTICAL INDUSTRIES LIMITED Proceeds from Income Tax Refunds
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Proceeds from Income Tax Refunds of $558.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from income tax refunds for fiscal 2025 was $558.00M, a 18.47% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from income tax refunds for fiscal 2024 was $471.00M, a 58.05% increase from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from income tax refunds for fiscal 2023 was $298.00M.
| Period end | Proceeds from Income Tax Refunds 12 month |
|---|---|
| 2025-12-31 | $558.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $471.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $298.00M 10-K · filed 2026-02-03 |